Strive Health joined the Unicorn Club in 2025 after raising a $300 million Series D equity round along with $250 million in debt financing. This milestone pushed the company to a $1.8 billion valuation. Headquartered in Denver, Colorado, United States, Strive Health delivers value-based kidney care across all stages of chronic kidney disease through predictive analytics, coordinated care teams, and integrated provider partnerships.
The company aims to improve outcomes for kidney disease patients by reducing hospitalisations, slowing disease progression, and delivering personalised care programs built around data-driven insights.
Keep reading to learn how Strive Health became a $1.8 billion leader transforming kidney care.
What Is Strive Health and What Does It Do?
Founded in 2018, Strive Health provides value-based kidney care for patients with chronic kidney disease and end-stage kidney disease. The company partners with payors, nephrologists, and health systems to manage high-risk kidney populations using predictive analytics, personalised care plans, multispecialty care teams, and continuous patient monitoring.
Strive Health helps reduce care fragmentation by coordinating care across nephrology, primary care, pharmacy, behavioural health, and speciality providers to support patients throughout the kidney care journey.
How Much Funding Has Strive Health Raised?
1. Series D Round
- Amount Raised: $300 million equity plus $250 million debt
- Date: 2025
- Valuation: $1.8 billion post-money
- Lead Investors: NEA, Hercules Capital, CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Redpoint
- Purpose: Expand value-based kidney care, scale multispecialty care teams, enhance predictive analytics, and grow payor and provider partnerships
2. Series C Round
- Amount Raised: $166 million
- Date: 2023
- Lead Investors: NEA, CVS Health Ventures, and others
- Purpose: Expand care delivery model, technology, and patient coverage across more regions
3. Earlier Rounds (Seed to Series B)
- Cumulative Funding: Not fully disclosed
- Key Investors: Early healthtech and value-based care investors
- Purpose: Build clinical infrastructure, scale early kidney care programs, and establish strategic partnerships
Total Funding Raised: More than $700 million
Latest Funding Date: 2025
Latest Known Valuation: $1.8 billion
Key Investors
- NEA
- Details: Global venture capital firm backing high-growth healthcare and technology companies
- Focus Areas: Value-based care, healthtech, clinical services, and data-driven care models
- CVS Health Ventures
- Details: Venture investment arm focused on accelerating healthcare innovation
- Focus Areas: Care delivery, chronic disease management, payor provider models, and digital health
- CapitalG
- Details: Growth stage investment fund supporting technology-enabled and analytics-driven companies
- Focus Areas: Healthtech, enterprise data platforms, and scalable care infrastructure
Where Is Strive Health’s Headquarters?
Strive Health is headquartered in Denver, Colorado, United States, supporting its clinical operations, technology development, care coordination, and national provider partnerships.
What’s Next for Strive Health?
Strive Health plans to expand its value-based kidney care model across additional states, scale multispecialty care teams, and strengthen collaborations with payors and nephrology groups. The company is also investing in analytics-driven risk prediction, patient engagement tools, and expanded care pathways to improve outcomes for patients with chronic kidney disease and end-stage kidney disease.
With substantial financial backing and a proven model, Strive Health is positioned to lead innovation in advanced kidney care nationwide.
Get Investor and Funding Insights with TexAu
TexAu provides verified investor and funding data for companies like Strive Health. Explore insights on value-based care, kidney disease management, and high-growth healthtech startups shaping the future of patient care.
Sign up for Free to access real-time investor and funding intelligence.
